ClearPoint Neuro, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ClearPoint Neuro, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • ClearPoint Neuro, Inc. Return On Equity for the quarter ending June 30, 2024 was -64.2 %, a 5.4% decline year-over-year.
  • ClearPoint Neuro, Inc. annual Return On Equity for 2023 was -83.9 %, a 111% decline from 2022.
  • ClearPoint Neuro, Inc. annual Return On Equity for 2022 was -39.8 %, a 27.5% decline from 2021.
  • ClearPoint Neuro, Inc. annual Return On Equity for 2021 was -31.2 %, a 92.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -83.9 -44.2 -111% Jan 1, 2023 Dec 31, 2023
2022 -39.8 -8.59 -27.5% Jan 1, 2022 Dec 31, 2022
2021 -31.2 +378 +92.4% Jan 1, 2021 Dec 31, 2021
2020 -410 -286 -232% Jan 1, 2020 Dec 31, 2020
2019 -124 +76.8 +38.3% Jan 1, 2019 Dec 31, 2019
2018 -200 -52.7 -35.7% Jan 1, 2018 Dec 31, 2018
2017 -148 -564 -135% Jan 1, 2017 Dec 31, 2017
2016 416 +221 +113% Jan 1, 2016 Dec 31, 2016
2015 195 +79.7 +69% Jan 1, 2015 Dec 31, 2015
2014 115 -49.9 -30.2% Jan 1, 2014 Dec 31, 2014
2013 165 +108 +187% Jan 1, 2013 Dec 31, 2013
2012 57.7 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.